Navigating analytical validation protocols for small-molecule enzyme inhibitors requires strict adherence to quantitative purity thresholds and spectroscopic verification. This technical guide outlines the High-Performance Liquid Chromatography (HPLC), Mass Spectrometry (MS), and endotoxin testing benchmarks necessary to evaluate 5-Amino-1MQ for preclinical research applications.
Navigating analytical validation protocols for small-molecule enzyme inhibitors requires strict adherence to quantitative purity thresholds and spectroscopic verification. This technical guide outlines the High-Performance Liquid Chromatography (HPLC), Mass Spectrometry (MS), and endotoxin testing benchmarks necessary to evaluate 5-Amino-1MQ for preclinical research applications.
5-Amino-1MQ (5-amino-1-methylquinolinium) is a selective, membrane-permeable small-molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT). In eukaryotic cells, NNMT catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), producing 1-methylnicotinamide (1-MNA). By blocking NNMT catalytic activity, 5-Amino-1MQ prevents the irreversible degradation of nicotinamide, thereby conserving cellular methyl donor pools and preserving intracellular precursor availability for key metabolic cascades.
In vitro and animal models demonstrate that NNMT inhibition via 5-Amino-1MQ leads to marked increases in intracellular nicotinamide adenine dinucleotide (NAD+) concentrations. Preclinical studies suggest that elevated NAD+ levels subsequently stimulate sirtuin-1 (SIRT1) activity and activate adenosine monophosphate-activated protein kinase (AMPK) signaling pathways. Consequently, researchers routinely utilize high-purity 5-Amino-1MQ in non-human models to investigate mitochondrial biogenesis, increased basal energy expenditure, mitochondrial output enhancement, and broad fat-metabolism research models. To ensure reproducible baseline data in metabolic assays, laboratory investigators must utilize reagents that meet validated chemical purity and identity metrics.
Although frequently categorized alongside synthetic peptides in metabolic literature, 5-Amino-1MQ is a synthetic quinolinium-derived small molecule rather than an amino acid polymer. It possesses a molecular formula of C10H11N2+ (typically synthesized as an iodide or chloride salt) and a precise monoisotopic mass of 159.09 g/mol (free cation). Because small molecules possess rigid chemical structures with distinct charge profiles, their analytical validation pathways differ from those of classical long-chain peptides.
Unlike peptide sequences susceptible to enzymatic cleavage or racemer formation during solid-phase synthesis, 5-Amino-1MQ synthesis risks distinct side products, including unreacted quinoline precursors, regioisomeric impurities, and residual counterions. Investigators conducting high-throughput screening or enzyme kinetic assays must ensure their supplier provides a verified 5-amino-1mq purity coa that documents total chemical purity, residual counterion stoichiometry, and absolute absence of unreacted synthetic intermediates.
High-Performance Liquid Chromatography (HPLC) serves as the primary quantitative method for determining the chemical purity of 5-Amino-1MQ. Reverse-phase HPLC (RP-HPLC) utilizing C18 stationary phases and UV/Vis spectrophotometric detection (typically monitored between 245 nm and 350 nm) resolves the parent molecule from degradation products, structural isomers, and synthesis side products.
For rigorous preclinical research, laboratories should mandate a minimum HPLC chromatographic purity threshold of ≥98.0%, with ideal analytical standards reaching ≥99.0% area-under-the-curve (AUC). A comprehensive HPLC chromatogram must show a sharp, symmetrical analyte peak with minimal tailing factor (typically between 0.8 and 1.2). Any secondary peaks corresponding to synthetic contaminants must be integrated, and individual impurities should not exceed 0.5% total peak area. Substandard purity profiles introduce confounding variables into enzymatic assays, potentially yielding false-positive or false-negative inhibition kinetics in NNMT activity screens.
While HPLC quantifies the relative concentration of the target molecule versus impurities, Electrospray Ionization Mass Spectrometry (ESI-MS) provides definitive confirmation of molecular weight and chemical identity. In positive ionization mode, 5-Amino-1MQ produces a primary molecular ion peak corresponding to its cationic species ([M]+) at m/z 159.1 ± 0.2.
A valid Certificate of Analysis (COA) must feature a clear MS spectrum showing the target m/z ion peak as the base peak (100% relative intensity). High-resolution mass spectrometry (HRMS) further validates the elemental composition by confirming exact mass matches within a 5 ppm error margin. The absence of extraneous m/z peaks in the spectrum verifies that the lot is free from unmethylated intermediates, dimerized side-products, or heavy metal contamination from synthetic catalysts. Researchers reviewing spectral data should confirm that peak fragmentation profiles align precisely with the theoretical molecular structure of 5-amino-1-methylquinolinium.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—pose a significant threat to cell culture models and preclinical animal studies. Even trace concentrations of endotoxin can trigger Toll-like receptor 4 (TLR4) activation, inducing inflammatory cytokine cascades (such as TNF-α, IL-6, and IL-1β) that confound experimental readouts in fat-metabolism research and mitochondrial assays.
Endotoxin levels in 5-Amino-1MQ batches are quantified using the chromogenic *Limulus* Amebocyte Lysate (LAL) assay or recombinant Factor C assay according to USP <85> guidelines. Standard laboratory thresholds require endotoxin levels to remain strictly below 0.1 EU/mg (Endotoxin Units per milligram), with high-grade research lots achieving <0.05 EU/mg. Ensuring stringent endotoxin control guarantees that observed physiological changes in cell viability, NAD+ concentration, or oxygen consumption rates are directly attributable to NNMT inhibition rather than immunogenic artifact responses. Additional information on quality benchmarks across our catalog can be explored in the PX1 Research Library.
A compliant, lot-specific Certificate of Analysis serves as the official quality passport for every batch of 5-Amino-1MQ. When evaluating a COA prior to experimental deployment, laboratory researchers must verify seven fundamental analytical criteria:
1. **Lot/Batch Identification:** Matches the physical vial label exactly, ensuring traceability across the supply chain. 2. **Physical Appearance:** Described as a crystalline or powder solid ranging from off-white to yellow, free from visible particulates. 3. **Chemical Identity Verification:** Confirmed via ESI-MS mass matching and/or 1H-NMR (Proton Nuclear Magnetic Resonance) spectroscopy. 4. **HPLC Purity Percentage:** Explicitly calculated via peak area integration, meeting or exceeding 98.0% purity. 5. **Endotoxin Level:** Reported in EU/mg as determined by an accredited LAL assay. 6. **Residual Solvents & Heavy Metals:** Confirmed compliant with ICH Q3C guidelines via Headspace Gas Chromatography (GC-MS). 7. **ISO Accredited Sign-Off:** Testing executed and validated by an independent ISO/IEC 17025 accredited laboratory facility.
In preclinical metabolic research, investigators frequently compare small-molecule enzymatic regulators like 5-Amino-1MQ against peptide-based metabolic modulators. While 5-Amino-1MQ operates via direct intracellular enzymatic inhibition of NNMT to increase NAD+ pools, other research peptides influence cellular energetic signaling pathways through receptor-mediated mechanisms.
For instance, MOTS-c is a mitochondrial-derived peptide that targets the folate-purine pathway to promote AMPK activation and metabolic homeostasis. In contrast, lipolytic research protocols often utilize signaling fragments such as AOD-9604, which mimics the C-terminal region of growth hormone to stimulate lipid catabolism without directly altering cellular NAD+ levels. Similarly, growth hormone secretagogues like Tesamorelin act upstream on the GHRH receptor to stimulate endogenous hormone release. Evaluating 5-Amino-1MQ alongside these compounds allows researchers to isolate distinct nodal controls within cellular energy management network models. For volume inquiries across diverse compound classes, laboratories may consult our wholesale research accounts division.
To maintain the chemical stability and analytical integrity of 5-Amino-1MQ post-sourcing, strict handling protocols must be observed in the laboratory environment. The lyophilisate or raw powder compound should be stored sealed at -20°C in a desiccated environment protected from light exposure, which prevents premature oxidation of the quinolinium core.
For in vitro assay preparation, 5-Amino-1MQ exhibits high solubility in dimethyl sulfoxide (DMSO) at concentrations exceeding 20 mg/mL, as well as moderate solubility in sterile aqueous buffers such as Phosphate-Buffered Saline (PBS, pH 7.4). Working stock solutions prepared in DMSO should be aliquoted into single-use microcentrifuge tubes and stored at -80°C to minimize freeze-thaw cycles. Prior to administration in cell culture models, researchers should ensure complete dissolution by gentle vortexing, followed by sterile filtration through a 0.22 µm PTFE or PVDF syringe filter to prevent microbial introduction into culture media.
PX1 Research enforces rigorous quality control protocols across all supplied research compounds. Every lot of 5-Amino-1MQ distributed by PX1 Research is synthesized in USA-based, GMP-compliant facilities and undergoes exhaustive analytical screening before release. Analytical testing is conducted in independent ISO 17025 accredited laboratories to ensure absolute objectivity and uncompromised precision.
PX1 Research guarantees that every lot includes an accessible, downloadable COA displaying lot-specific HPLC chromatograms, mass spectra, and quantitative LAL endotoxin data. Sourced compounds are stored in climate-controlled environments and dispatched with same-day shipping (Monday through Friday) from our primary fulfillment centers in California and Arizona. By prioritizing chemical purity, structural validation, and rapid logistics, PX1 Research provides academic and corporate laboratories with reliable reagents required for high-impact preclinical research.
What is the minimum purity requirement for 5-Amino-1MQ on a COA?
For reliable preclinical research, 5-Amino-1MQ must exhibit an HPLC chromatographic purity of at least 98.0%, with high-grade research lots reaching ≥99.0%. Lower purity levels introduce unknown synthetic intermediates that can interfere with enzymatic NNMT assays.
How does 5-Amino-1MQ increase cellular NAD+ in research models?
5-Amino-1MQ acts as a selective inhibitor of nicotinamide N-methyltransferase (NNMT). By blocking NNMT, it prevents the methylation and clearance of nicotinamide (NAM), thereby conserving NAM for salvage pathway synthesis into NAD+.
Which analytical techniques are required to confirm 5-Amino-1MQ structural identity?
Structural identity is verified using Electrospray Ionization Mass Spectrometry (ESI-MS) to confirm the parent m/z ion peak at 159.1 [M]+, alongside Proton Nuclear Magnetic Resonance (1H-NMR) spectroscopy to validate chemical structure.
Why is endotoxin testing critical for 5-Amino-1MQ in cellular research?
Endotoxins (LPS) activate TLR4 receptors on cells, triggering inflammatory responses that can distort metabolic data, confound cytokine readouts, and alter mitochondrial function independent of NNMT inhibition.
What is the maximum acceptable endotoxin threshold for 5-Amino-1MQ?
Standard laboratory specifications require endotoxin levels to be less than 0.1 EU/mg, with premium research lots achieving levels under 0.05 EU/mg as measured by LAL assay testing.
How should 5-Amino-1MQ powder be stored in the laboratory?
Lyophilized powder should be stored sealed at -20°C in a dry, dark environment. Reconstituted stock solutions in DMSO should be aliquoted and maintained at -80°C to preserve chemical integrity.
Is 5-Amino-1MQ classified as a peptide?
No. 5-Amino-1MQ is a synthetic quinolinium-derived small molecule, not an amino acid chain or peptide sequence. However, it is frequently studied alongside metabolic peptides due to its effects on cellular energetic pathways.
What solvent is recommended for 5-Amino-1MQ reconstitution?
DMSO (Dimethyl Sulfoxide) is the primary recommended solvent for high-concentration stock solutions (>20 mg/mL). Aqueous buffers like PBS can be used for working concentrations depending on assay compatibility.
How does PX1 Research verify lot-to-lot consistency for 5-Amino-1MQ?
PX1 Research subjects every synthesized batch to independent ISO 17025 accredited testing, conducting HPLC, MS, and LAL endotoxin assays per lot to guarantee stringent quality compliance.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.